Jane Street Group, LLC Mannkind Corp Put Options Transaction History

Jane Street Group, LLC

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$5.01 - $6.7 $64,629 - $86,430	12,900 New	12,900 $81,000
Q1 2022 May 17, 2022	SELL	$2.62 - $4.45 $18,864 - $32,040	-7,200 Reduced 14.57%	42,200 $155,000
Q4 2021 Feb 15, 2022	SELL	$4.05 - $5.37 $26,730 - $35,442	-6,600 Reduced 11.79%	49,400 $216,000
Q3 2021 Nov 16, 2021	SELL	$3.89 - $5.48 $13,615 - $19,180	-3,500 Reduced 5.88%	56,000 $244,000
Q2 2021 Aug 16, 2021	BUY	$3.61 - $5.45 $69,312 - $104,640	19,200 Added 47.64%	59,500 $324,000
Q1 2021 May 18, 2021	BUY	$3.14 - $6.14 $126,542 - $247,442	40,300 New	40,300 $158,000

250

149M

1.62M

802K

Ticker MNKD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 257,338,000
Market Cap $1.45B
Description
MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Jane Street Group, LLC with notifications on news.